CONMED HEMOSTASIS: payments to doctors
Payments that named CONMED HEMOSTASIS as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $280K
- Providers
- 677
- Transactions
- 1,059
- Average per transaction
- $264
The per-transaction average — $264 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 677 providers the average total is $414, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Conmed Corporation | $200,187 | 71.5% |
| Linvatec Corporation | $79,864 | 28.5% |